Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: Aftercare Focus Study (AFS): A Clinical Trial to Reduce Short-Term Suicide Risk After Hospitalization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing an aftercare intervention to reduce short-term suicide risk after hospitalization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Suicidal Ideation, Suicide, Attempted | Phase 2 | Status: COMPLETED